Achieve Life Sciences (ACHV) Retained Earnings (2010 - 2026)
Achieve Life Sciences' (ACHV) quarterly Retained Earnings came in at -$270.4 million in Q1 2026, down 4506666.67% YoY from N/an in Q1 2025, and down 2704040.0% on a QoQ basis from $10000.0 in Q4 2025.
Achieve Life Sciences (ACHV) Retained Earnings (2010 - 2026) Analysis & Trends
Achieve Life Sciences (ACHV) has 17 years of Retained Earnings data on file, last reported at -$270.4 million in Q1 2026.
- Quarterly Retained Earnings fell 4506666.67% year-over-year to -$270.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$270.4 million (down 4506666.67% YoY) and the FY2025 annual result came in at $10000.0, down 67.74% from the prior year.
- Retained Earnings slipped to -$270.4 million in Q1 2026, from $10000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $31000.0 in Q4 2024 to a low of -$270.4 million in Q1 2026.
- A 5-year average of -$88.0 million and a median of -$101.2 million in 2022 frame the typical range for Retained Earnings.
- The widest YoY moves for Retained Earnings: up 100.02% in 2024, down 4830550.0% in 2024.
- Tracing ACHV's Retained Earnings over 5 years: stood at $4000.0 in 2022, then plunged by 4143875.0% to -$165.8 million in 2023, then jumped by 100.02% to $31000.0 in 2024, then tumbled by 67.74% to $10000.0 in 2025, then sank by 2704040.0% to -$270.4 million in 2026.
- The last three Retained Earnings figures came in at -$270.4 million (Q1 2026), $10000.0 (Q4 2025), and $9000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Achieve Life Sciences | 330.88 Mn | 330.88 Mn | - | -345.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -345.20 Mn |
| Mar 31, 2026 | -270.39 Mn |
| Dec 31, 2025 | 10,000.00 |
| Sep 30, 2025 | 9,000.00 |
| Jun 30, 2025 | -231.12 Mn |
| Mar 31, 2025 | 6,000.00 |
| Dec 31, 2024 | 31,000.00 |
| Sep 30, 2024 | -193.22 Mn |
| Jun 30, 2024 | -7,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Dec 31, 2023 | -165.75 Mn |
| Sep 30, 2023 | 4,000.00 |
| Jun 30, 2023 | -153.17 Mn |
| Mar 31, 2023 | -144.90 Mn |
| Dec 31, 2022 | 4,000.00 |
| Sep 30, 2022 | -124.70 Mn |
| Jun 30, 2022 | -111.60 Mn |
| Mar 31, 2022 | -101.20 Mn |
| Dec 31, 2021 | 4,000.00 |
| Sep 30, 2021 | 4,000.00 |